Skip to main content
. 2022 Nov 9;31(2):195–201. doi: 10.1038/s41431-022-01220-9

Table 2.

Hormonal and biochemical at baseline and after 1 and 2 years of rGH therapy.

IGF-Ia, ng/mL (nv 65–225) IGF-Ia, SDS Glycemia, mg/dL (nv 80–100) Insulin, IU/L (nv 1.8–24) TSHb, mIU/L (nv 0.26–4.2) Free T4c, pg/mL (nv 8–17)
Twin A (GHDd)
  Baseline 53 −2.02 83 8.0 1.76 10.6
  1 year 172 0.66 90 10.4
  2 years 164 0.49 91 11.2 1.5 10.3
Twin B (SGAe)
  Baseline 52 −2.05 84 7.3 1.83 12.7
  1 year 149 0.1 89 11.8
  2 years 170 0.61 92 8.4 1.37 11.8

1Insulin-like Growth Factor-I.

bThyroid Stimulating Hormone.

cThyroxine.

dGrowth Hormone Deficiency.

eSmall for Gestational Age.